(Q46917397)

English

Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology

scientific article published on 29 January 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16444267

Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16444267

0 references

author name string

Julia Alter

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16444267

Fang Lou

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16444267

Adam Rabinowitz

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16444267

HaiFang Yin

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16444267

Jeffrey Rosenfeld

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16444267

Steve D Wilton

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16444267

Terence A Partridge

7

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16444267

Qi Long Lu

8

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16444267

language of work or name

0 references

publication date

29 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16444267

Nature Medicine

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16444267

12

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16444267

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16444267

175-177

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16444267

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

1 reference

https://api.crossref.org/works/10.1038%2FNM1345

7 January 2021

based on heuristic

inferred from DOI database lookup

Very mild muscular dystrophy associated with the deletion of 46% of dystrophin

1 reference

https://api.crossref.org/works/10.1038%2FNM1345

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic delivery of genes to striated muscles using adeno-associated viral vectors.

1 reference

https://api.crossref.org/works/10.1038%2FNM1345

7 January 2021

based on heuristic

inferred from DOI database lookup

Screening for antisense modulation of dystrophin pre-mRNA splicing

1 reference

https://api.crossref.org/works/10.1038%2FNM1345

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy.

1 reference

https://api.crossref.org/works/10.1038%2FNM1345

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse

1 reference

https://api.crossref.org/works/10.1038%2FNM1345

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles

1 reference

https://api.crossref.org/works/10.1038%2FNM1345

7 January 2021

based on heuristic

inferred from DOI database lookup

Antisense technologies. Improvement through novel chemical modifications

1 reference

https://api.crossref.org/works/10.1038%2FNM1345

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemically delivered antisense oligomers upregulate gene expression in mouse tissues

1 reference

https://api.crossref.org/works/10.1038%2FNM1345

7 January 2021

based on heuristic

inferred from DOI database lookup

Morpholino antisense oligomers: design, preparation, and properties

1 reference

https://api.crossref.org/works/10.1038%2FNM1345

7 January 2021

based on heuristic

inferred from DOI database lookup

Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements

1 reference

https://api.crossref.org/works/10.1038%2FNM1345

7 January 2021

based on heuristic

inferred from DOI database lookup

Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle.

1 reference

https://api.crossref.org/works/10.1038%2FNM1345

7 January 2021

based on heuristic

inferred from DOI database lookup

Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping

1 reference

https://api.crossref.org/works/10.1038%2FNM1345

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16444267

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16444267

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46917397&oldid=2208247549"